AliExpress targeted by EU “formal investigation” for distribution of dangerous products. The Chinese online commerce giant is suspected of not having respected its obligations to combat the sale of fake medicines.
At the beginning of November, the European Commission sent a request for information to this subsidiary of the Chinese internet giant Alibaba. Based on the preliminary investigation, it decided to open a formal procedure under the new Digital Services Regulation (DSA) intended to better protect consumers, according to a European source.